Antigens targeted by prevalent pathogenic T cells in type 1 diabetes and uses thereof

Details for Australian Patent Application No. 2004278652 (hide)

Owner Albert Einstein College of Medicine of Yeshiva University

Inventors Santamaria, Pere; Evans, Anne M.; Lieberman, Scott M.; Dilorenzo, Teresa P.; Shabanowitz, Jeffrey; Nathenson, Stanley G.; Hunt, Donald F.

Agent Shelston IP

Pub. Number AU-A-2004278652

PCT Pub. Number WO2005/033267

Priority 60/471,868 20.05.03 US

Filing date 20 May 2004

Wipo publication date 14 April 2005

International Classifications

A61K 38/04 (2006.01) Medicinal preparations containing peptides - Peptides having up to 20 amino acids in a fully defined sequence

Event Publications

12 January 2006 PCT application entered the National Phase

  PCT publication WO2005/033267 Priority application(s): WO2005/033267

6 March 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004278655-Scroll compressor with offset scroll members

2004278637-Refrigeration apparatus